HomeCompareGNR vs JNJ

GNR vs JNJ: Dividend Comparison 2026

GNR yields 2.30% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GNR wins by $3.1K in total portfolio value
10 years
GNR
GNR
● Live price
2.30%
Share price
$74.67
Annual div
$1.72
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.1K
Annual income
$266.79
Full GNR calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — GNR vs JNJ

📍 GNR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGNRJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GNR + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GNR pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GNR
Annual income on $10K today (after 15% tax)
$195.46/yr
After 10yr DRIP, annual income (after tax)
$226.77/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $476.84/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GNR + JNJ for your $10,000?

GNR: 50%JNJ: 50%
100% JNJ50/50100% GNR
Portfolio after 10yr
$21.6K
Annual income
$547.28/yr
Blended yield
2.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GNR
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GNR buys
0
JNJ buys
0
No recent congressional trades found for GNR or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGNRJNJ
Forward yield2.30%3.36%
Annual dividend / share$1.72$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$23.1K$20.0K
Annual income after 10y$266.79$827.78
Total dividends collected$2.5K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GNR vs JNJ ($10,000, DRIP)

YearGNR PortfolioGNR Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,930$229.96$10,676$355.77+$254.00GNR
2$11,930$234.90$11,407$389.39+$523.00GNR
3$13,005$239.62$12,198$426.53+$807.00GNR
4$14,159$244.12$13,056$467.62+$1.1KGNR
5$15,399$248.40$13,987$513.12+$1.4KGNR
6$16,729$252.47$14,998$563.56+$1.7KGNR
7$18,156$256.34$16,098$619.52+$2.1KGNR
8$19,687$260.01$17,295$681.69+$2.4KGNR
9$21,329$263.49$18,599$750.82+$2.7KGNR
10$23,089$266.79$20,022$827.78+$3.1KGNR

GNR vs JNJ: Complete Analysis 2026

GNRStock

The State Street SPDR S&P Global Natural Resources ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Global Natural Resources Index (the "Index")Seeks to provide exposure to a number of the largest market cap securities in three natural resources sectors - agriculture, energy, and metals and miningMaximum weight of each sub-index is capped at one-third of the total weight of the Index

Full GNR Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this GNR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GNR vs SCHDGNR vs JEPIGNR vs OGNR vs KOGNR vs MAINGNR vs ABBVGNR vs MRKGNR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.